A new painkiller has been approved for sale. This medication, Journavx, is a step forward that skips those addictive opioids that many of us are familiar with. Think of it as a shortcut around the addiction crisis. This pain reliever tackles those intense, short-term pains from things like surgery,
Aphasia is a tough condition. It makes speaking or understanding language hard. Many people get it after a stroke. Self-management strategies can really help stroke survivors live better. But what about those with aphasia? They often get overlooked in research. So, can self-management help them too
In the realm of randomized clinical trials, researchers have been trying to figure out if certain markers can predict how well a patient with early breast cancer will do in the long run. Early breast cancer is a challenging problem. One of the key challenges is knowing how effective a treatment
You might think that when it comes to early-stage lung cancer, the more you remove, the better. But hold on a minute! Recent studies show that sublobar resection, which removes just a part of the lung, might be just as good as removing the whole lobe. However, if the cancer has invaded the lung's pl
Spirituality has been hinted to boost patient outcomes, although it hasn't been thoroughly tested in clinical trials yet. Imagine this: a condition like hypertension, a leading cause of heart disease globally, might be influenced by something other than medications. Enter the FEEL Trial, which delve
Psychedelics have been part of human culture for centuries, with strong links to spiritual practices. Now, scientists are exploring their potential to heal mental health issues like PTSD, depression, and anxiety. These drugs work by changing how brain areas communicate with each other, making the br
Imagine you're trying to find a solution to a big problem, like cancer. To make sure your solution works for everyone, you need people from all walks of life to test it out. But sometimes, certain groups are left out. That's exactly what happens in clinical trials. The NHS-Galleri trial is trying t
Imagine you’ve just had a heart procedure and your doctor wants to know how you're feeling. Instead of waiting for your appointment, you can now share your health journey directly. This is what electronic patient-reported outcome (PRO) systems aim to do in outpatient cardiovascular care. While that
Imagine you're running a clinical trial to test a new treatment in critical care. You're tracking how patients do after the treatment, but what if some patients don't make it long enough to see the full results? That's what we're calling "truncation due to death. " The big question is, how do we han
Every year, over 60 million people face traumatic brain injuries (TBIs), leading to significant health issues and even death. Managing these injuries is tough, with a heavy toll on individuals and society. For the past couple of decades, there's been a rise in clinical trials focusing on neurocriti
